Literature DB >> 20129015

Relative hypoparathyroidism and hypoalbuminemia are associated with hip fracture in hemodialysis patients.

B Al Helal1, W S Su, D N Churchill, A S Gangji.   

Abstract

AIMS: Patients with end-stage renal disease treated by hemodialysis are at an increased risk of hip fracture. In the general population, hip fractures are associated with increased morbidity and mortality. The objective of this study was to assess the predictors and outcomes of hip fracture in the hemodialysis population, including quality of life post hip fracture.
METHODS: A case-control study from 1999 to 2005 included 29 adult hemodialysis patients with hip fracture and 55 controls, matched on age, gender and number of years on hemodialysis. A logistic regression model was used to derive predictors of hip fracture. The association between time to death post hip fracture and parathyroid hormone was analyzed using a Kaplan-Meier curve. The ability to live independently 1 year after hip fracture was used as a measure of quality of life.
RESULTS: Variables associated with hip fracture were a reduction in serum parathyroid hormone by 100 pg/ml (OR = 1.65, 95% CI 1.10, 2.46) and a decrease in serum albumin by 1 g/l (OR = 1.18, 95% CI 1.00, 1.39). 40% of the cases died within the first year post hip fracture. Median survival time in patients with hip fracture and a serum PTH value < 100 pg/ml was 17 days (95% CI 0, 37 days) as compared with 280 days (95% CI 103, 471 days) for those with a PTH value > 100 pg/ml (p < 0.02). Among the patients who survived, 53% were subsequently discharged to a long-term care facility.
CONCLUSIONS: Relative hypoparathyroidism and hypoalbuminemia are associated with an increased risk of hip fracture in hemodialysis patients. There is also a significant reduction in quality of life in patients sustaining a hip fracture.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20129015     DOI: 10.5414/cnp73088

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  7 in total

1.  Factors and Outcome of Renal Osteodystrophy-Associated Initial Fragility Fracture in End-Stage Renal Disease Patients.

Authors:  Cai Li; Xue-Mei Chen; Yin Li; Yan-Lin Zhou; Jia-Ni Yan; Xiao-Gang Du
Journal:  Kidney Dis (Basel)       Date:  2019-02-06

2.  Hypoalbuminemia is a risk factor for predicting early postoperative complications after proximal humerus fracture fixation.

Authors:  Molly Vora; David C Sing; Paul H Yi; Jonathan W Cheah; Xinning Li
Journal:  J Orthop       Date:  2019-11-26

3.  Nutritional Insufficiency as a Predictor for Adverse Outcomes in Adult Spinal Deformity Surgery.

Authors:  Kevin Phan; Jun S Kim; Joshua Xu; John Di Capua; Nathan J Lee; Parth Kothari; Khushdeep S Vig; James Dowdell; Samuel K Cho
Journal:  Global Spine J       Date:  2017-06-30

4.  Thirty-Day Perioperative Complications, Prolonged Length of Stay, and Readmission Following Elective Posterior Lumbar Fusion Associated With Poor Nutritional Status.

Authors:  Kevin Phan; William Ranson; Samuel J W White; Zoe B Cheung; Jun Kim; John I Shin; Chierika Ukogu; Nathan J Lee; Parth Kothari; Samuel K Cho
Journal:  Global Spine J       Date:  2018-08-29

5.  Efficacy of Ultrasound-guided Radiofrequency Ablation of Parathyroid Hyperplasia: Single Session vs. Two-Session for Effect on Hypocalcemia.

Authors:  Zeng Zeng; Cheng-Zhong Peng; Ji-Bin Liu; Yi-Wen Li; Hong-Feng He; Qiao-Hong Hu; Bo Lin; Xiao-Gang Shen
Journal:  Sci Rep       Date:  2020-04-10       Impact factor: 4.379

6.  Prevalence and predictors of asymptomatic vertebral fracture in patients with end-stage renal disease.

Authors:  Sasipim Jirasirirak; Sinee Disthabanchong; Boonsong Ongphiphadhanakul; Sakda Arj-Ong Vallibhakara; Hataikarn Nimitphong
Journal:  Heliyon       Date:  2022-03-23

7.  Micropetrosis in hemodialysis patients.

Authors:  Aiji Yajima; Ken Tsuchiya; David B Burr; Taro Murata; Masaki Nakamura; Masaaki Inaba; Yoshihiro Tominaga; Tatsuhiko Tanizawa; Takashi Nakayama; Akemi Ito; Kosaku Nitta
Journal:  Bone Rep       Date:  2021-11-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.